Aluminum Hydroxide Clinical Trials

All Categories Medications / Interventions » Aa » Aluminum Hydroxide

Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

Condition: Malaria
Interventions: Biological: Pfs25-EPA; Biological: Pfs25-EPA/Alhydrogel
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2012
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant

Conditions: Hookworm Infection; Hookworm Disease
Interventions: Biological: 10 μg Na-GST-1/Alhydrogel; Biological: 30 μg Na-GST-1/Alhydrogel; Biological: 100 μg Na-GST-1/Alhydrogel; Biological: 10 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF; Biological: 30 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF; Biological: 100 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF; Biological: 10 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF; Biological: 30 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF; Biological: 100 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF
Sponsors: Albert B. Sabin Vaccine Institute; Albert B. Sabin Vaccine Institute; Children's Research Institute; George Washington University
Recruiting - verified May 2012
Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

Condition: SARS
Interventions: Drug: Aluminum hydroxide adjuvant (Alhydrogel®); Other: Phosphate buffered saline Placebo; Biological: Recombinant S protein SARS vaccine
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified April 2012
Phase I STEBVax in Healthy Adults

Condition: Staphylococcus Enterotoxin B
Intervention: Biological: STEBVax
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2012
Multisite Controlled Trial of Cocaine Vaccine

Condition: Cocaine Dependence
Interventions: Drug: TA-CD Vaccination; Other: Placebo Injection
Sponsors: Baylor College of Medicine; Baylor College of Medicine; National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs Cooperative Studies Program; VA Maryland Health Care System; Columbia University; VA New York Harbor Healthcare System; University of Pennsylvania; Johns Hopkins University; University of Cincinnati; Celtic Pharma Development Services
Recruiting - verified September 2011